New epidemiological study finds no connection between cases of cancer and use of plant protection products containing glyphosate

January 12, 2018

To do so, the researchers evaluated as yet unpublished data from the Agricultural Health Study (AHS) in the USA, the observation period of which had been extended by eleven years. Through the extended follow-up of the AHS, they come to the conclusion that no significant connections could be established between applications of plant protection products containing glyphosate and the occurrence of cancer among the examined population group. This applies to cancers in general, as well as to special cancer types, such as non-Hodgkin lymphoma, which has been discussed in connection with the glyphosate assessment. The results suggesting a possible association with acute myeloid leukaemia (AML) are not statistically unambiguous and should be interpreted with caution.

The BfR has made an initial assessment of the new study, which was published in the Journal of the National Cancer Institute (djx233, https://doi.org/10.1093/jnci/djx233). The study was not taken into consideration by the IARC or in the concluded European health assessment of glyphosate presented in the course of the application for its re-approval as an active substance in plant protection products.

http://www.bfr.bund.de/cm/349/glyphosate-new-epidemiological-study-finds-no-connection-between-cases-of-cancer-and-use-of-plant-protection-products-containing-glyphosate.pdf

More information on the topic of glyphosate at the BfR website http://www.bfr.bund.de/en/a-z_index/glyphosate-193962.html
-end-


BfR Federal Institute for Risk Assessment

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.